STAT

Opinion: Traumatic brain injury should be a factor when judging individuals accused of crimes

Traumatic brain injury is common among people who are incarcerated. Since such injuries affect judgment and impulse control, individuals accused of crimes should be checked for them when they are…
An analysis of the brain of former NFL player Aaron Hernandez showed severe chronic traumatic encephalopathy — a progressive degenerative brain disease often seen in people with a history of repetitive brain trauma.

Can a traumatic brain injury increase the odds that an individual will commit a crime? And if the answer is yes, should such an injury factor into how we judge people accused of crimes?

Those questions occurred to me when I read about the latest twist in the case of Aaron Hernandez, a former tight end for the New England Patriots, who had been convicted of murdering Odin Lloyd, a semi-professional football player who had been dating the sister of Hernandez’s fiancee. While on trial for Lloyd’s murder, Hernandez was charged with shooting and killing two other men, but was acquitted in 2017. Days after that he killed himself in his prison cell.

A team of Boston University researchers was asked to examine Hernandez’s brain. — a progressive degenerative brain disease often seen in people with a history of repetitive brain trauma — they had ever seen in a person his age. While experts are using their customary scientific caution in not connecting Hernandez’s brain pathology to his crime, such severe injuries would have caused poor judgment and impulse control, two hallmarks of the bad behavior that landed Hernandez in prison for life.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks